Clinical trial
MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events - a Prospective Cohort Study
NCT05773235 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events - a Prospective Cohort Study
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- June 30, 2024
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
caa - cerebral amyloid angiopathy, cerebral small vessel diseases, intracerebral hemorrhage